1. Home
  2. EVG vs ACOG Comparison

EVG vs ACOG Comparison

Compare EVG & ACOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eaton Vance Short Diversified Income Fund Eaton Vance Short Duration Diversified Income Fund of Beneficial Interest

EVG

Eaton Vance Short Diversified Income Fund Eaton Vance Short Duration Diversified Income Fund of Beneficial Interest

HOLD

Current Price

$10.97

Market Cap

148.1M

Sector

Finance

ML Signal

HOLD

Logo Alpha Cognition Inc.

ACOG

Alpha Cognition Inc.

HOLD

Current Price

$5.52

Market Cap

130.9M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVG
ACOG
Founded
2005
2000
Country
United States
Canada
Employees
N/A
N/A
Industry
Investment Managers
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
148.1M
130.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
EVG
ACOG
Price
$10.97
$5.52
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$18.00
AVG Volume (30 Days)
49.4K
84.0K
Earning Date
01-01-0001
11-13-2025
Dividend Yield
8.68%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$7,427,199.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$143.70
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.13
$3.75
52 Week High
$10.86
$11.54

Technical Indicators

Market Signals
Indicator
EVG
ACOG
Relative Strength Index (RSI) 41.68 35.86
Support Level $10.89 $5.66
Resistance Level $11.03 $6.74
Average True Range (ATR) 0.12 0.41
MACD -0.00 -0.01
Stochastic Oscillator 27.86 0.00

Price Performance

Historical Comparison
EVG
ACOG

About EVG Eaton Vance Short Diversified Income Fund Eaton Vance Short Duration Diversified Income Fund of Beneficial Interest

Eaton Vance Short Duration Diversified Income Fund is a diversified, closed-end management investment company. Its primary investment objective is to provide a high level of current income with a secondary objective of seeking capital appreciation to the extent consistent with its primary goal. The portfolio of investments consists of business equipment and services, automotive, cable and satellite television, chemicals and plastics, food products, and other areas.

About ACOG Alpha Cognition Inc.

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

Share on Social Networks: